(People with chronic hepatitis B infection). All people with cirrhosis based on clinical evidence (or APRI or transient elastography score) require lifelong treatment with nucleos(t)ide analogues and should not discontinue antiviral therapy because of the risk of reactivation, which can cause an acute hepatitis flare